ACS :: What Women Should Know About HPV And Cervical Health P The FDA has approved the use of the test for human papilloma virus, or HPV,as a screening tool for cervical cancer. Here are some common questions about http://www.cancer.org/docroot/NWS/content/NWS_2_1x_What_Women_Should_Know_about_
Extractions: The FDA has approved the use of the test for human papilloma virus, or HPV, as a screening tool for cervical cancer. Here are some common questions about HPV and cervical cancer, and who should consider getting an HPV test. ACS News Center Medical Updates News You Can Use Stories of Hope ... I Want to Help You can help in the fight against cancer. Donate and volunteer. It's easy and fun! Learn more What Women Should Know about HPV and Cervical Health Article date: A new test is now out for a virus called the human papilloma (pap-ah-loma-ah) virus, or HPV. HPV can lead to cervix cancer. This document answers some common questions about HPV and cervix cancer, and who should think about having an HPV test. What is cervix cancer? How common is it? Cervix cancer begins in the cervix, the part of the womb (or uterus) that opens to the vagina. Cervix cancer was once the number one cause of death due to cancer in women. Thanks to the Pap test, which helps doctors find cervix cancer, not as many women in the US get the disease. What is HPV? How does it lead to cervix cancer?
Women's Cancer Network cervical cancer Presentation Download cervical cancer Screening, Evaluation, Treatment presentation. http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126
Cervical Cancer Note Separate PDQ summaries on Screening for cervical cancer and Prevention The prognosis for patients with cervical cancer is markedly affected by the http://www.meb.uni-bonn.de/cancer.gov/CDR0000062759.html
Extractions: More Information Note: Separate PDQ summaries on Screening for Cervical Cancer and Prevention of Cervical Cancer are also available. Note: Estimated new cases and deaths from cervical (uterine cervix) cancer in the United States in 2005: [ The prognosis for patients with cervical cancer is markedly affected by the extent of disease at the time of diagnosis. Because a vast majority (greater than 90%) of these cases can and should be detected early through the use of the Pap smear, [ ] the current death rate is far higher than it should be and reflects that, even today, Pap smears are not done on approximately one third of eligible women. Among the major factors that influence prognosis are stage, volume and grade of tumor, histologic type, lymphatic spread, and vascular invasion. In a large surgicopathologic staging study of patients with clinical stage IB disease reported by the Gynecologic Oncology Group (GOG), the factors that predicted most prominently for lymph node metastases and a decrease in disease-free survival were capillary-lymphatic space involvement by tumor, increasing tumor size, and increasing depth of stromal invasion with the latter being most important and reproducible. [ ] In a study of 1,028 patients treated with radical surgery, survival rates correlated more consistently with tumor volume (as determined by precise volumetry of the tumor) than clinical or histologic stage. [
Cervical Cancer UK - Jo's Trust Offers information on cervical cancer, chemotherapy, counseling and related issues, bulletin board and relevant links. Also Jo's story and how the trust came to be established. http://www.jotrust.co.uk
Extractions: Welcome to Jo's Trust, the charity dedicated to fighting cervical cancer. James and Jo Maxwell established the Trust in 1999 with the belief that it could make a difference to the lives of women and their families affected by pre-cancer and cancer of the cervix. Making a Difference www.jotrust.co.uk provides good information, confidential expert medical advice, counselling and support about all aspects of cervical cancer. Awareness and knowledge of the causes of pre-cancer and cervical cancer with an understanding of the importance of having regular cervical screening can prevent this disease. Read the most up to date medical information available on About Cervical Cancer Use our Confidential Medical Advice forum to submit a question or concern to our online medical panel. Post a message on the Bulletin Board and correspond with other women or go to our News page and read the latest stories about developments in the prevention and treatment of pre-cancer and cervical cancer. Our new
Cancer Watch Online Volumes Issues Articles http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126
Cervical Cancer There are usually no noticeable signs of early cervical cancer but it can be Treatment of cervical cancer during pregnancy depends on the stage of the http://www.meb.uni-bonn.de/cancer.gov/CDR0000062961.html
Extractions: About PDQ Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. The cervix is the lower, narrow end of the uterus (the hollow, pear-shaped organ where a fetus grows). The cervix leads from the uterus to the vagina (birth canal). Cervical cancer usually develops slowly over time. Before cancer appears in the cervix, the cells of the cervix go through changes known as dysplasia , in which cells that are not normal begin to appear in the cervical tissue . Later, cancer cells start to grow and spread more deeply into the cervix and to surrounding areas. Human papillomavirus (HPV) infection is the major risk factor for development of cervical cancer. Infection of the cervix with human papillomavirus (HPV) is the most common cause of cervical cancer. Not all women with HPV infection, however, will develop cervical cancer. Women who do not regularly have a Pap smear to detect HPV or abnormal cells in the cervix are at increased risk of cervical cancer.
Cervical Cancer cervical cancer is cancer in the cervix, the lower, narrow part of the uterus The good news is that there are ways to help prevent cervical cancer. http://www.4woman.gov/faq/ccervix.htm
Extractions: Where can I learn more about cervical cancer? Cancer is a disease in which certain body cells don't function right, divide very fast, and produce too much tissue that forms a tumor. Cervical cancer is cancer in the cervix, the lower, narrow part of the uterus (womb). The uterus is the hollow, pear-shaped organ where a baby grows during a woman's pregnancy. The cervix forms a canal that opens into the vagina (birth canal), which leads to the outside of the body. Cervical cancer is a disease that can be very serious. However, it is a disease that you can help prevent. Cervical cancer occurs when normal cells in the cervix change into cancer cells. This normally takes several years to happen, but it can also happen in a very short period of time. The good news is that there are ways to help prevent cervical cancer. By getting regular Pap tests and pelvic exams, your health care provider can find and treat the changing cells before they turn into cancer. Where can I learn more about cervical cancer?
Cervical Screening Multimedia Courseware Offers physical assessment of the female reproductive system and the clinical procedure of obtaining a Pap Smear. Demo available. http://cervicalcancer.hypermart.net/
Extractions: About the Software: The "Strategy" to prepare public health nurses for certification of competency in the physical assessment of the female reproductive system and the clinical procedure of obtaining a Papanicolaou Smear. The "Objectives" Identify the location of female reproductive organs. Discuss the normal developmental changes of the female reproductive system. Develop interview questions to obtain information about the patient's reproductive health status. Explain specimen collection of the Papanicolaou smear. Identify the equipment used during the Pap smear and explain their use. Document findings of the assessment of the female reproductive system. About the process: After identifying a product to develop and gaining support for the idea from the Cervical Cancer Initiative, I wrote the "Proposal" requesting funding from the various government support agencies and submitted it on behalf of the Cervical Cancer Initiative. The project obtained "Funding" from Human Resources Development Canada to hire (6) students. I then took the job description that was included with the proposal and interviewed and selected a "Team" of (2) Animators, (2) Lingo Programmers, (1) Story Boarder / Multimedia Writer, (1) Volunteer Portfolio Designer and Beta Tester and (1) Project Manager.
Screening: Cervical Cancer The USPSTF strongly recommends screening for cervical cancer in women who havebeen sexually active and have a cervix. Rating A recommendation. http://www.ahrq.gov/clinic/uspstf/uspscerv.htm
Extractions: Release Date: January 2003 Summary of Recommendations Supporting Documents The USPSTF strongly recommends screening for cervical cancer in women who have been sexually active and have a cervix. Rating: A recommendation Rationale : The USPSTF found good evidence from multiple observational studies that screening with cervical cytology (Pap smears) reduces incidence of and mortality from cervical cancer. Direct evidence to determine the optimal starting and stopping age and interval for screening is limited. Indirect evidence suggests most of the benefit can be obtained by beginning screening within 3 years of onset of sexual activity or age 21 (whichever comes first) and screening at least every 3 years ( go to Clinical Considerations ). The USPSTF concludes that the benefits of screening substantially outweigh potential harms. The USPSTF recommends against routinely screening women older than age 65 for cervical cancer if they have had adequate recent screening with normal Pap smears and are not otherwise at high risk for cervical cancer (go to Clinical Considerations Rating: D recommendation Rationale : The USPSTF found limited evidence to determine the benefits of continued screening in women older than 65. The yield of screening is low in previously screened women older than 65 due to the declining incidence of high-grade cervical lesions after middle age. There is fair evidence that screening women older than 65 is associated with an increased risk for potential harms, including false-positive results and invasive procedures. The USPSTF concludes that the potential harms of screening are likely to exceed benefits among older women who have had normal results previously and who are not otherwise at high risk for cervical cancer.
WINGS - Reproductive Health For Women And Men In Guatemala Nongovernmental organization providing reproductive health care, education, family planning and birth control, cervical cancer screening, and other reproductive health care. Program information, success stories, and how to donate. http://www.wingsguate.org
Extractions: Search September 19, 2005 Registration Healthcare Professionals You are in: Cancer and Tumors The uterine cervix is the lowest portion of a woman's uterus (womb). Most of the uterus lies in the pelvis, but part of the cervix is located in the vagina, where it connects the uterus with the vagina. Cancer of the cervix occurs when the cells of the cervix change in a way that leads to abnormal growth and invasion of other tissues or organs of the body. Like all cancers, cancer of the cervix is much more likely to be cured if it is detected early and treated immediately. One of the key features of cervical cancer is its slow progression from normal cervical tissue, to precancerous (or dysplastic) changes in the tissue, to invasive cancer. These opportunities have caused the decline of cervical cancer over the past decades in the United States. Invasive cancer means that the cancer affects the deeper tissues of the cervix and may have spread to other parts of the body. This spread is called metastasis. Cervical cancers don't always spread, but those that do most often spread to the lungs, the liver, the bladder, the vagina, and/or the rectum.
Screening For Cervical Cancer: Recommendations And Rationale Discontinuation of cervical cancer screening in older women is appropriate In the absence of studies with cervical cancer outcomes, the USPSTF concluded http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.htm
Extractions: This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for cervical cancer and the supporting scientific evidence, and updates the 1996 recommendation contained in the Guide to Clinical Preventive Services , Second Edition The USPSTF strongly recommends screening for cervical cancer in women who have been sexually active and have a cervix. Rating: A recommendation Rationale: The USPSTF found good evidence from multiple observational studies that screening with cervical cytology (Pap smears) reduces incidence of and mortality from cervical cancer. Direct evidence to determine the optimal starting and stopping age and interval for screening is limited. Indirect evidence suggests most of the benefit can be obtained by beginning screening within 3 years of onset of sexual activity or age 21 (whichever comes first) and screening at least every 3 years ( go to Clinical Considerations ). The USPSTF concludes that the benefits of screening substantially outweigh potential harms.
Extractions: Welcome to the Irish Cervical Screening Programme Website This is Phase 1 of a National Cervical Screening Programme, which offers free cervical screening to women aged 25-60 years in the Mid-Western Health Board (MWHB) area. Women aged 25-60 years in the MWHB area are invited to Register with the Programme. The ICSP aims to ensure that women on the Register will be invited over a 5 year screening period, by letter to attend for a free cervical smear test. Women who have never had a Programme smear can contact one of the ICSP Registered Smeartakers (Doctors and Nurses) to discuss having a free smear test. Or Women who have registered with the Programme can wait until they are sent a letter advising when to make an appointment for a free smear test with an ICSP Registered Smeartaker of their choice.
Extractions: Gynecologic cancers are diagnosed in female reproductive organs that include the uterus, ovaries, cervix, fallopian tubes, vulva, and vagina. Each year, thousands of women are diagnosed with some form of gynecologic cancer. Each year, thousands of women die from gynecologic cancers. CDC supports several initiatives to reduce the burden of gynecologic cancer that include surveillance; screening (where recommended); research; and public and health care provider education and awareness to increase knowledge of incidence and mortality, risk factors, symptoms, and prevention strategies. Visit
TriPath Imaging®, Inc Develops, manufactures and markets integrated sample preparation and automated image analysis system to support cytologists in cervical cancer screening. (Nasdaq TPTH). http://www.tripathimaging.com/
Extractions: TriPath Imaging , Inc., headquartered in Burlington, North Carolina, develops, manufactures, markets, and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging, and treatment. TriPath was formed in September 1999 through the merger of AutoCyte, Inc. and NeoPath, Inc. and acquisition of the technology and intellectual property of Neuromedical Systems, Inc. We were created to leverage the complementary nature of the products, technologies, and intellectual property developed by our predecessor companies, all of whom were early pioneers in the application of computerized image processing and analysis to detect the often subtle cellular abnormalities associated with cancer and its precursors. Through our Commercial Operations group, we have developed and are marketing an effective solution for
Extractions: Breast and Cervical Cancer You may also download a PDF version (567K) for Adobe Acrobat Reader On this page The National Breast and Cervical Cancer Early Detection Program , administered by the Centers for Disease Control and Prevention (CDC), helps low-income, uninsured, and underserved women gain access to lifesaving screening programs for early detection of breast and cervical cancers. Many deaths from breast and cervical cancers could be avoided by increasing cancer screening rates among women at risk. Deaths from these diseases occur disproportionately among women who are uninsured or underinsured. Mammography and Papanicolaou (Pap) tests are underused by women who have less than a high school education, are older, live below the poverty level, or are members of certain racial and ethnic minority groups. Studies show that early detection of breast and cervical cancers saves lives. Timely mammography screening among women aged 40 years or older could prevent approximately 16% of all deaths from breast cancer. Pap tests can find cervical cancer at an early stage when it is most curable, or even prevent the disease if precancerous lesions found during the test are treated.
MediSpectra, Inc., Lexington, Massachusetts A medical device company developing proprietary optical detection technology for enhanced accuracy and realtime results in the diagnosis of cervical cancer. http://www.medispectra.com/
Ladies First/ Vermont Department Of Health Information on the state's first comprehensive breast and cervical cancer screening system, which removes the financial barriers which have prevented many women from being screened, by offering free lifesaving cancer screening to women ages 4064 with limited income. http://www.healthyvermonters.info/hs/epi/cdepi/cancer/ladiesfirst/index.html
Extractions: Welcome to Ladies First! Ladies First is a health screening program for Vermont women. Ladies First removes financial barriers which prevents many women from being screened for cancer or heart disease. Federally funded through a grant to the Health Department, Ladies First pays for annual mammograms, clinical breast exams, pelvic exams, Pap tests, instruction in breast self-exam, and cardiovascular disease risk factor (cholesterol, high blood pressure, diabetes) screening. Services are provided locally, by the woman's own physician in most cases. Ladies First also pays for repeat mammograms, ultrasounds, biopsies, and colposcopies. Early and regular screening is key to reducing the death rate from cancer and heart disease. Women who are older or have limited income are at higher risk to develop cancer and heart disease, and less likely to be screened for cancer. Find out more... TOP OF PAGE Vermont Department of Health